Catalyst Wire Dossier Catalyst Wire Dossier

Locoid

hydrocortisone 17-butyrate 0.1%
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Locoid, covering 2017-03-17 to 2017-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis [Phase 4]

See pricing